Dr. Matthew J Donovan, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10 Market Place Dr, York, ME 03909 Phone: 207-363-6400 Fax: 207-363-8816 |
John Thomas Albright, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 16 Hospital Drive, York, ME 03909 Phone: 207-363-3700 |
News Archive
New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.
People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2009.
The U.S. Department of Health and Human Services' Office of Minority Health, North Shore Medical Labs, Inc. and the American Health Information Management Association recently announced a demonstration project to foster broader adoption and use of Electronic Health Records and support national efforts to reduce health disparities affecting minorities in underserved areas.
Pfizer Inc. announced today that based on discussions with the U.S. Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for the treatment of relapsed acute myeloid leukemia (AML)) in the United States and that it will be voluntarily withdrawing the new drug application (NDA) for Mylotarg effective October 15, 2010.
› Verified 8 days ago